PBYI Financials | Income, Balance Sheet & Cash Flow
The financial statements for PBYI (PBYI) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| ABEO Abeona Therapeutics Inc. | $5.38 -1.82% |
| B Barrick Mining Corporation | $40.46 -5.82% |
| TRDA Entrada Therapeutics, Inc. | $13.07 -3.61% |
| ARCT Arcturus Therapeutics Holdings Inc. | $8.82 -0.90% |
| AVIR Atea Pharmaceuticals, Inc. | $5.52 -3.33% |
| ELDN Eledon Pharmaceuticals, Inc. | $3.96 -4.35% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| ABEO Abeona Therapeutics Inc. | $5.38 | -1.82% | 306.92 M | 5.33 | 1.01 | 0.00% | Buy | 721 |
| B Barrick Mining Corporation | $40.46 | -5.82% | 67.79 B | 13.81 | 2.93 | 1.48% | Buy | 11.79 |
| TRDA Entrada Therapeutics, Inc. | $13.07 | -3.61% | 500.38 M | -3.77 | -3.47 | 0.00% | Buy | 96 |
| ARCT Arcturus Therapeutics Holdings Inc. | $8.82 | -0.90% | 250.69 M | -3.59 | -2.46 | 0.00% | Buy | 290 |
| AVIR Atea Pharmaceuticals, Inc. | $5.52 | -3.33% | 439.79 M | -2.85 | -1.94 | 0.00% | Hold | 370 |
| ELDN Eledon Pharmaceuticals, Inc. | $3.96 | -4.35% | 237.40 M | -7.62 | -0.52 | 0.00% | Buy | 2.13 |
Frequently Asked Questions
What are PBYI's latest financial results?
Review PBYI's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has PBYI's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is PBYI's cash flow situation and liquidity?
Cash flow statements reveal how PBYI generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does PBYI's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether PBYI is outperforming or lagging within its sector.
Are PBYI's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether PBYI's profits are repeatable and supported by strong fundamentals.